News on Michael Ezekowitzhttp://howtoavoidaheartattack.com/topic/michael-ezekowitz2010-10-27T08:45:23ZFreezing, Medicating Away a Dangerous Irregular Heart Rhythm2010-10-27T08:45:23ZHealthCentral.comtag:howtoavoidaheartattack.com,2010-10-27:/cardiovascular-medicine/freezing-medicating-dangerous-irregular-heart-rhythm-3463069a/...Merck and Portola: Finding a Blood Thinner’s Sweet Spot2010-10-25T11:36:48ZWall Street Journal Health Blogtag:howtoavoidaheartattack.com,2010-10-25:/cardiovascular-medicine/merck-portola-finding-blood-thinner238217s-sweet-spot-3153314a/...Several Atrial Fibrillation Approaches Assessed2010-10-25T11:34:34ZModern Medicinetag:howtoavoidaheartattack.com,2010-10-25:/cardiovascular-medicine/atrial-fibrillation-approaches-assessed-3151476a/...Experimental blood-thinner effective: study2010-03-15T08:15:53ZAFP Global Editiontag:howtoavoidaheartattack.com,2010-03-15:/cardiovascular-medicine/experimental-bloodthinner-effective-study-874331a/<div><p>An experimental blood thinner developed by Merck and <a title="Portola Pharmaceuticals Inc." href="/topic/Portola+Pharmaceuticals+Inc." >Portola Pharmaceuticals</a> was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.</p><p>The Phase II randomized trial compared the effects of betrixaban, which is part of a new class of drugs, to the widely used warfarin in 508 patients in the <a title="United States" hre...Experimental Merck blood-thinner found effective2010-03-15T07:16:02ZAFP American Editiontag:howtoavoidaheartattack.com,2010-03-15:/cardiovascular-medicine/experimental-merck-bloodthinner-effective-874264a/<div><p>An experimental blood thinner developed by Merck and <a title="Portola Pharmaceuticals Inc." href="/topic/Portola+Pharmaceuticals+Inc." >Portola Pharmaceuticals</a> was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.</p><p>The Phase II randomized trial compared the effects of betrixaban, which is part of a new class of drugs, to the widely used warfarin in 508 patients in the <a title="United States" hre...Promising Results of Drug Trial Could Herald a Replacement for Popular Blood Thinner2010-10-24T09:16:21ZDrugs.comtag:howtoavoidaheartattack.com,2010-10-24:/cardiovascular-medicine/promising-results-drug-trial-herald-replacement-popular-blood-thinner-3012074a/...